Patents by Inventor Hyang Hee Cho

Hyang Hee Cho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10736929
    Abstract: The present invention relates to a method for preparing an herbal composition with increased fat-soluble polyphenols, an herbal composition prepared by the method, and a use of the composition. The herbal composition with increased fat-soluble polyphenols of the present invention is characterized by the significantly increased content of fat-soluble polyphenols including decursin, compared with the herbal composition of comparative example, and also demonstrates a significant anti-oxidative activity, immune cell activating effect, and cancer cell growth inhibitory effect, significantly reduces renal toxicity and liver toxicity induced by the anticancer agent cisplatin back so as to be almost normal condition, and significantly inhibits the intestinal crypt loss caused by irradiation, compared with the herbal composition of comparative example.
    Type: Grant
    Filed: October 10, 2016
    Date of Patent: August 11, 2020
    Assignee: KOREA ATOMIC ENERGY RESEARCH INSTITUTE
    Inventors: Sung-Kee Jo, Hae Ran Park, Uhee Jung, Ho Yong Lee, Hyang Hee Cho
  • Publication number: 20190038690
    Abstract: The present invention relates to a method for preparing an herbal composition with increased fat-soluble polyphenols, an herbal composition prepared by the method, and a use of the composition. The herbal composition with increased fat-soluble polyphenols of the present invention is characterized by the significantly increased content of fat-soluble polyphenols including decursin, compared with the herbal composition of comparative example, and also demonstrates a significant anti-oxidative activity, immune cell activating effect, and cancer cell growth inhibitory effect, significantly reduces renal toxicity and liver toxicity induced by the anticancer agent cisplatin back so as to be almost normal condition, and significantly inhibits the intestinal crypt loss caused by irradiation, compared with the herbal composition of comparative example.
    Type: Application
    Filed: October 10, 2016
    Publication date: February 7, 2019
    Applicant: KOREA ATOMIC ENERGY RESEARCH INSTITUTE
    Inventors: Sung-Kee Jo, Hae Ran Park, Uhee Jung, Ho Yong Lee, Hyang Hee Cho